HCV Infection and Chronic Renal Disease

Sekulic, Sofija; Mijailovic, Zeljko; Petrovic, Dejan; Lukic, Ruzica; Jovanovic, Marina; Jovanovic, Ivan

doi:10.2478/sjecr-2021-0010

References

1. Chan ST, Ou JJ. Hepatitis C Virus-Induced Autophagy and Host Innate Immune Response. Viruses. 2017;9(8):224.10.3390/v9080224558048128805674
Search in Google Scholar Back to article
2. Li H, Huang MH, Jiang JD, Peng ZG. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy. World J Gastroenterol. 2018;24(47):5297-5311.10.3748/wjg.v24.i47.5297630553030598575
Search in Google Scholar Back to article
3. Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host – Virus Interaction and Mechanisms of Viral Persistence. Cells. 2019;8(4):376.10.3390/cells8040376652373431027278
Search in Google Scholar Back to article
4. Wilkins T, Akhtar M, Gititu E, Jalluri C, Ramirez J. Diagnosis and Management of Hepatitis C. Am Fam Physician. 2015;91(12):835-842.
Search in Google Scholar Back to article
5. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3(2):47-52.10.7150/ijms.3.47
Search in Google Scholar Back to article
6. Manns MP, Buti M, Gane E, et al. Hepatitis C virus infection. Nat Rev Dis Primers. 2017;3:17006.10.1038/nrdp.2017.628252637
Search in Google Scholar Back to article
7. Coppola N, Alessio L, Onorato L, et al. Epidemiology and management of hepatitis C virus infections in immigrant populations. Infect Dis Poverty. 2019;8(1):17.10.1186/s40249-019-0528-6641937030871599
Search in Google Scholar Back to article
8. Ansaldi F, Orsi A, Sticchi L, Bruzzone B, Icardi G. Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World J Gastroenterol. 2014;20(29):9633-9652.10.3748/wjg.v20.i29.9633412335525110404
Search in Google Scholar Back to article
9. Di Biagio A, Taramasso L, Cenderello G. Treatment of hepatitis C virus genotype 4 in the DAA era. Virol J. 2018;15(1):180.10.1186/s12985-018-1094-4625114330466446
Search in Google Scholar Back to article
10. Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit Rev Microbiol. 2010;36(2):91-133.10.3109/1040841090335745520345213
Search in Google Scholar Back to article
11. Negro F. Steatosis and insulin resistance in response to treatment of chronic hepatitis C. J Viral Hepat. 2012;19 Suppl 1:42-47.10.1111/j.1365-2893.2011.01523.x22233413
Search in Google Scholar Back to article
12. van der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;308(24):2584-2593.10.1001/jama.2012.14487823268517
Search in Google Scholar Back to article
13. Goossens N, Negro F. Is genotype 3 of the hepatitis C virus the new villain?. Hepatology. 2014;59(6):2403-2412.10.1002/hep.2690524155107
Search in Google Scholar Back to article
14. Kuna L, Jakab J, Smolic R, Wu GY, Smolic M. HCV Extrahepatic Manifestations. J Clin Transl Hepatol. 2019;7(2):172-182.10.14218/JCTH.2018.00049660984431293918
Search in Google Scholar Back to article
15. Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol. 2001;75(15):7059-7066.10.1128/JVI.75.15.7059-7066.200111443411435586
Search in Google Scholar Back to article
16. Heim MH, Thimme R. Innate and adaptive immune responses in HCV infections. J Hepatol. 2014;61(1 Suppl):S14-S25.10.1016/j.jhep.2014.06.03525443342
Search in Google Scholar Back to article
17. Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61(1 Suppl):S58-S68.10.1016/j.jhep.2014.07.01225443346
Search in Google Scholar Back to article
18. Kinchen VJ, Bailey JR. Defining Breadth of Hepatitis C Virus Neutralization. Front Immunol. 2018;9:1703.10.3389/fimmu.2018.01703608292330116237
Search in Google Scholar Back to article
19. Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host – Virus Interaction and Mechanisms of Viral Persistence. Cells. 2019;8(4):376.10.3390/cells8040376652373431027278
Search in Google Scholar Back to article
20. Baskic D, Vukovic V, Popovic S, et al. Correction: Chronic Hepatitis C: Conspectus of immunological events in the course of fibrosis evolution. PLoS One. 2019;14(8):e0221142.10.1371/journal.pone.0221142668716431393958
Search in Google Scholar Back to article
21. Khatun M, Ray RB. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis. Cells. 2019;8(10):1249.10.3390/cells8101249682958631615075
Search in Google Scholar Back to article
22. Liu X, Xu J, Brenner DA, Kisseleva T. Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts. Curr Pathobiol Rep. 2013;1(3):209-214.10.1007/s40139-013-0018-7375725224000319
Search in Google Scholar Back to article
23. Spengler U, Nattermann J. Immunopathogenesis in hepatitis C virus cirrhosis. Clin Sci (Lond). 2007;112(3):141-155.10.1042/CS2006017117199558
Search in Google Scholar Back to article
24. Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA. 2007;297(7):724-732.10.1001/jama.297.7.72417312292
Search in Google Scholar Back to article
25. Czepiel J, Biesiada G, Mach T. Viral hepatitis C. Pol Arch Med Wewn. 2008;118(12):734-740.10.20452/pamw.542
Search in Google Scholar Back to article
26. Morozov VA, Lagaye S. Hepatitis C virus: Morphogenesis, infection and therapy. World J Hepatol. 2018;10(2):186-212.10.4254/wjh.v10.i2.186583843929527256
Search in Google Scholar Back to article
27. Dias C, Pipa S, Mota M. Acute hepatitis C from heterosexual transmission. IDCases. 2018;14:e00448.10.1016/j.idcr.2018.e00448612576130191131
Search in Google Scholar Back to article
28. Blackard JT, Shata MT, Shire NJ, Sherman KE. Acute hepatitis C virus infection: a chronic problem [published correction appears in Hepatology. 2008 Feb;47(2):769]. Hepatology. 2008;47(1):321-331.10.1002/hep.21902227749618161707
Search in Google Scholar Back to article
29. Younossi Z, Park H, Henry L, Adeyemi A, Stepanova M. Extrahepatic Manifestations of Hepatitis C: A Metaanalysis of Prevalence, Quality of Life, and Economic Burden. Gastroenterology. 2016;150(7):1599-1608.10.1053/j.gastro.2016.02.03926924097
Search in Google Scholar Back to article
30. Sayiner M, Golabi P, Farhat F, Younossi ZM. Dermatologic Manifestations of Chronic Hepatitis C Infection. Clin Liver Dis. 2017;21(3):555-564.10.1016/j.cld.2017.03.01028689593
Search in Google Scholar Back to article
31. Cacoub P, Comarmond C, Desbois AC, Saadoun D. Rheumatologic Manifestations of Hepatitis C Virus Infection. Clin Liver Dis. 2017;21(3):455-464.10.1016/j.cld.2017.03.00228689585
Search in Google Scholar Back to article
32. Goossens N, Negro F. Cardiovascular Manifestations of Hepatitis C Virus. Clin Liver Dis. 2017;21(3):465-473.10.1016/j.cld.2017.03.00328689586
Search in Google Scholar Back to article
33. Mapoure NY, Budzi MN, Eloumou SAFB, Malongue A, Okalla C, Luma HN. Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study. PLoS One. 2018;13(3):e0192406.10.1371/journal.pone.0192406584165529513678
Search in Google Scholar Back to article
34. Couronné L, Bachy E, Roulland S, et al. From hepatitis C virus infection to B-cell lymphoma. Ann Oncol. 2018;29(1):92-100.10.1093/annonc/mdx63529045541
Search in Google Scholar Back to article
35. Flores-Chávez A, Carrion JA, Forns X, Ramos-Casals M. Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection. Rev Esp Sanid Penit. 2017;19(3):87-97.
Search in Google Scholar Back to article
36. Tang L, Marcell L, Kottilil S. Systemic manifestations of hepatitis C infection. Infect Agent Cancer. 2016;11:29.10.1186/s13027-016-0076-7487804027222662
Search in Google Scholar Back to article
37. Ozkok A, Yildiz A. Hepatitis C virus associated glomerulopathies. World J Gastroenterol. 2014;20(24):7544-7554.10.3748/wjg.v20.i24.7544406928624976695
Search in Google Scholar Back to article
38. Park H, Chen C, Wang W, Henry L, Cook RL, Nelson DR. Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD. Hepatology. 2018;67(2):492-504.10.1002/hep.29505581473028873225
Search in Google Scholar Back to article
39. Guss D, Sherigar J, Rosen P, Mohanty SR. Diagnosis and Management of Hepatitis C Infection in Primary Care Settings. J Gen Intern Med. 2018;33(4):551-557.10.1007/s11606-017-4280-y588077129352420
Search in Google Scholar Back to article
40. Maasoumy B, Wedemeyer H. Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenterol. 2012;26(4):401-412.10.1016/j.bpg.2012.09.00923199500
Search in Google Scholar Back to article
41. Karnsakul W, Schwarz KB. Hepatitis B and C. Pediatr Clin North Am. 2017;64(3):641-658.10.1016/j.pcl.2017.01.007543326228502443
Search in Google Scholar Back to article
42. Zeuzem S, Berg T, Moeller B, et al. Expert opinion on the treatment of patients with chronic hepatitis C. J Viral Hepat. 2009;16(2):75-90.10.1111/j.1365-2893.2008.01012.x275998718761607
Search in Google Scholar Back to article
43. González-Grande R, Jiménez-Pérez M, González Arjona C, Mostazo Torres J. New approaches in the treatment of hepatitis C. World J Gastroenterol. 2016;22(4):1421-1432.10.3748/wjg.v22.i4.1421472197726819511
Search in Google Scholar Back to article
44. Tsukiyama-Kohara K, Kohara M. Hepatitis C Virus: Viral Quasispecies and Genotypes. Int J Mol Sci. 2017;19(1):23.10.3390/ijms19010023579597429271914
Search in Google Scholar Back to article
45. Simonović Babić J, Bojović K, Fabri M, Cvejić T, Svorcan P, Noţić D, Jovanović M, Škrbić R, Stojiljković MP, Mijailović Ţ. A real-life data on the efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in patients with genotype 1 chronic hepatitis C virus infection in Serbia. Vojnosanit Pregl. 2019; 76(5): 531–536.10.2298/VSP170727186S
Search in Google Scholar Back to article
46. Kim S, Han KH, Ahn SH. Hepatitis C Virus and Antiviral Drug Resistance. Gut Liver. 2016;10(6):890-895.10.5009/gnl15573508792727784846
Search in Google Scholar Back to article
47. Heim MH. 25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end. Nat Rev Immunol. 2013;13(7):535-542.10.1038/nri346323743475
Search in Google Scholar Back to article
48. Bojovic K, Simonovic-Babic J, Mijailovic Z, et al. Micro- elimination of HCV as a possible therapeutic strategy: our experience and a review of literature. J Infect Dev Ctries. 2020;14(2):117-124.10.3855/jidc.1178532146444
Search in Google Scholar Back to article
49. Akchurin OM. Chronic Kidney Disease and Dietary Measures to Improve Outcomes. Pediatr Clin North Am. 2019;66(1):247-267.10.1016/j.pcl.2018.09.007662397330454747
Search in Google Scholar Back to article
50. Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008;35(2):329-vii.10.1016/j.pop.2008.01.008247478618486718
Search in Google Scholar Back to article
51. Cobo G, Lindholm B, Stenvinkel P. Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant. 2018;33(suppl_3):iii35-iii40.10.1093/ndt/gfy175616880130281126
Search in Google Scholar Back to article
52. Fraser SD, Blakeman T. Chronic kidney disease: identification and management in primary care. Pragmat Obs Res. 2016;7:21-32.10.2147/POR.S97310508776627822135
Search in Google Scholar Back to article
53. Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease [published correction appears in Clin Exp Nephrol. 2019 Mar 2;:]. Clin Exp Nephrol. 2019;23(4):437-447.10.1007/s10157-018-1641-8643562630178234
Search in Google Scholar Back to article
54. Razmaria AA. Chronic Kidney Disease. JAMA. 2016;315(20):2248.10.1001/jama.2016.142627218648
Search in Google Scholar Back to article
55. Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017;389(10075):1238-1252.10.1016/S0140-6736(16)32064-5
Search in Google Scholar Back to article
56. Breyer MD, Susztak K. Developing Treatments for Chronic Kidney Disease in the 21st Century. Semin Nephrol. 2016;36(6):436-447.10.1016/j.semnephrol.2016.08.001542340427987541
Search in Google Scholar Back to article
57. Petrović D, Miloradović V, Poskurica M, Stojimirović B. Srp Arh Celok Lek. 2011;139(3-4):248-255.10.2298/SARH1104248P
Search in Google Scholar Back to article
58. Lee WC, Lee YT, Li LC, et al. The Number of Comorbidities Predicts Renal Outcomes in Patients with Stage 3–5 Chronic Kidney Disease. J Clin Med. 2018;7(12):493.10.3390/jcm7120493630690630486496
Search in Google Scholar Back to article
59. Reichel H, Zee J, Tu C, et al. Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2020;35(5):803-810.10.1093/ndt/gfz260720356031953939
Search in Google Scholar Back to article
60. Wigneswaran J, Van Wyck D, Pegues D, Gholam P, Nissenson AR. Hepatitis C virus infection in patients with end-stage renal disease. Hemodial Int. 2018;22(3):297-307.10.1111/hdi.1267230141571
Search in Google Scholar Back to article
61. Lukic R, Gajovic N, Jovanovic I, Jurisevic M, Mijailovic Z, Maric V, Popovska Jovicic B, Arsenijevic N. Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients. Disease Markers olume 2017; 2017:Article ID 627598710.1155/2017/6275987540556928487598
Search in Google Scholar Back to article
62. Azmi AN, Tan SS, Mohamed R. Hepatitis C and kidney disease: An overview and approach to management. World J Hepatol. 2015;7(1):78-92.10.4254/wjh.v7.i1.78429519725624999
Search in Google Scholar Back to article
63. Caragea DC, Mihailovici AR, Streba CT, et al. Hepatitis C Infection in Hemodialysis Patients. Curr Health Sci J. 2018;44(2):107-112.
Search in Google Scholar Back to article
64. Lukic R, Cupic M, Gajovic N, et al. Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection. J Infect Dev Ctries. 2020;14(5):519-526.10.3855/jidc.1174132525839
Search in Google Scholar Back to article
65. Nguyen DB, Bixler D, Patel PR. Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention. Semin Dial. 2019;32(2):127-134.10.1111/sdi.12761641105530569604
Search in Google Scholar Back to article
66. Cacoub P, Desbois AC, Isnard-Bagnis C, Rocatello D, Ferri C. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal. J Hepatol. 2016;65(1 Suppl):S82-S94.10.1016/j.jhep.2016.06.01127641990
Search in Google Scholar Back to article
67. Henson JB, Sise ME. The association of hepatitis C infection with the onset of CKD and progression into ESRD. Semin Dial. 2019;32(2):108-118.10.1111/sdi.12759641072830496620
Search in Google Scholar Back to article

HCV Infection and Chronic Renal Disease

References

Paradigm

My account